Skip to content

Anaphase-promoting complex subunit 2 (ANAPC2)

Homo sapiens — UniProt Q9UJX6

Gene: ANAPC2Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Anaphase-promoting complex subunit 2 (ANAPC2) is a protein from Homo sapiens identified by UniProt accession Q9UJX6, 822 residues long. MolForge cross-references it against 0 known binders and 30 disease associations.

  • UniProt accession: Q9UJX6; gene symbol ANAPC2.
  • Organism: Homo sapiens.
  • Length: 822 amino acids.
  • Top disease associations (Open Targets): low grade glioma, breast adenocarcinoma and ovarian cancer.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameAnaphase-promoting complex subunit 2
UniProt accessionQ9UJX6
GeneANAPC2
OrganismHomo sapiens
Length822 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (30)

Diseases linked to this target (Open Targets).

  • low grade glioma · score 0.25
  • breast adenocarcinoma · score 0.25
  • ovarian cancer · score 0.23
  • neurodegenerative disease · score 0.22
  • endometrial cancer · score 0.18
  • lung adenocarcinoma · score 0.18
  • clear cell renal carcinoma · score 0.18
  • esophageal cancer · score 0.13
  • eosinophil percentage of leukocytes · score 0.12
  • sitting height measurement · score 0.12

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9UJX6-F1alphafoldPREDICTED78.73—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9UJX6.

Amino-acid sequence (822 residues)

MAAAVVVAEG DSDSRPGQEL LVAWNTVSTG LVPPAALGLV SSRTSGAVPP KEEELRAAVE VLRGHGLHSV LEEWFVEVLQ NDLQANISPE FWNAISQCEN SADEPQCLLL LLDAFGLLES RLDPYLRSLE LLEKWTRLGL LMGTGAQGLR EEVHTMLRGV LFFSTPRTFQ EMIQRLYGCF LRVYMQSKRK GEGGTDPELE GELDSRYARR RYYRLLQSPL CAGCSSDKQQ CWCRQALEQF HQLSQVLHRL SLLERVSAEA VTTTLHQVTR ERMEDRCRGE YERSFLREFH KWIERVVGWL GKVFLQDGPA RPASPEAGNT LRRWRCHVQR FFYRIYASLR IEELFSIVRD FPDSRPAIED LKYCLERTDQ RQQLLVSLKA ALETRLLHPG VNTCDIITLY ISAIKALRVL DPSMVILEVA CEPIRRYLRT REDTVRQIVA GLTGDSDGTG DLAVELSKTD PASLETGQDS EDDSGEPEDW VPDPVDADPG KSSSKRRSSD IISLLVSIYG SKDLFINEYR SLLADRLLHQ FSFSPEREIR NVELLKLRFG EAPMHFCEVM LKDMADSRRI NANIREEDEK RPAEEQPPFG VYAVILSSEF WPPFKDEKLE VPEDIRAALE AYCKKYEQLK AMRTLSWKHT LGLVTMDVEL ADRTLSVAVT PVQAVILLYF QDQASWTLEE LSKAVKMPVA LLRRRMSVWL QQGVLREEPP GTFSVIEEER PQDRDNMVLI DSDDESDSGM ASQADQKEEE LLLFWTYIQA MLTNLESLSL DRIYNMLRMF VVTGPALAEI DLQELQGYLQ KKVRDQQLVY SAGVYRLPKN CS

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with ANAPC2?

The strongest Open Targets associations for ANAPC2 are low grade glioma, breast adenocarcinoma, ovarian cancer, neurodegenerative disease and endometrial cancer.

How long is the ANAPC2 protein?

The Homo sapiens ANAPC2 protein (UniProt Q9UJX6) is 822 amino acids long.

Browse: Targets: A · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Anaphase-promoting complex subunit 2 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9UJX6
GeneANAPC2
OrganismHomo sapiens
Length822
Binders0
Diseases30
View on UniProt